The Value of Addition of Human Menopausal Gonadotropin Drug Following Oocytes Retrieval in IVF Cycles

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The aim of this study is to test the hypothesis that addition of daily small dose of human menopausal gonadotropin (HMG) drug following oocytes retrieval could improve the fertility outcome in women undergoing in-vitro fertilization
Epistemonikos ID: d843935694eca88563946d04ad483877c4bc3b2c
First added on: May 20, 2024